VPPM Holdings — ProFund VP Pharmaceuticals
All 60 reported holdings of ProFund VP Pharmaceuticals (VPPM) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Enliven Therapeutics Inc | 2.35% | $239.16K |
| Corcept Therapeutics Inc. | 2.20% | $223.76K |
| Terns Pharmaceuticals Inc. | 2.08% | $211.09K |
| Perrigo Company PLC | 2.02% | $205.05K |
| Axsome Therapeutics Inc. | 1.95% | $198.43K |
| Innoviva Inc | 1.91% | $194.65K |
| Merck & Co., Inc | 1.91% | $193.91K |
| Pfizer Inc. | 1.89% | $192.63K |
| Royalty Pharma PLC | 1.89% | $192.41K |
| Elanco Animal Health Inc | 1.88% | $191.13K |
| Jazz Pharmaceuticals PLC | 1.88% | $190.94K |
| Esperion Therapeutics Inc | 1.88% | $190.79K |
| Edgewise Therapeutics Inc. | 1.87% | $190.35K |
| MBX Biosciences, Inc. | 1.87% | $190.11K |
| Definium Therapeutics Inc. | 1.87% | $190.00K |
| Bristol-Myers Squibb Company | 1.86% | $189.41K |
| ANI Pharmaceuticals Inc. | 1.86% | $188.79K |
| Johnson & Johnson | 1.85% | $188.46K |
| Tarsus Pharmaceuticals Inc | 1.85% | $188.00K |
| Trevi Therapeutics Inc | 1.84% | $187.13K |
| Pacira Biosciences Inc | 1.82% | $185.41K |
| Zoetis Inc. | 1.82% | $184.76K |
| Crinetics Pharmaceuticals Inc. | 1.81% | $183.96K |
| Nektar Therapeutics | 1.81% | $183.76K |
| Liquidia Corporation | 1.80% | $183.30K |
| Amneal Pharmaceuticals Inc | 1.80% | $183.16K |
| Harmony Biosciences Holdings Inc | 1.79% | $182.21K |
| Supernus Pharmaceuticals, Inc | 1.79% | $181.90K |
| Viatris Inc | 1.78% | $181.12K |
| Xeris Biopharma Holdings Inc | 1.77% | $179.52K |
| Harrow Inc | 1.76% | $178.77K |
| Organon & Co | 1.72% | $175.29K |
| Nuvation Bio Inc | 1.72% | $175.04K |
| Phibro Animal Health Corporation | 1.72% | $174.83K |
| Amylyx Pharmaceuticals Inc | 1.71% | $174.36K |
| Collegium Pharmaceutical Inc. | 1.71% | $173.88K |
| Indivior Pharmaceuticals Inc. | 1.71% | $173.89K |
| Eli Lilly & Co. | 1.69% | $172.00K |
| Prestige Consumer Healthcare Inc | 1.68% | $171.29K |
| Ligand Pharmaceuticals Incorporated | 1.66% | $169.10K |
| Ocular Therapeutix Inc | 1.64% | $166.99K |
| Omeros Corp | 1.63% | $165.78K |
| Eyepoint Inc. | 1.59% | $161.81K |
| Alumis Inc | 1.54% | $156.63K |
| Amphastar Pharmaceuticals Inc | 1.39% | $141.50K |
| Phathom Pharmaceuticals Inc | 1.38% | $140.60K |
| Theravance Biopharma Inc | 1.36% | $138.41K |
| Rapport Therapeutics Inc | 1.31% | $133.51K |
| Arvinas Inc | 1.20% | $121.76K |
| CorMedix Inc. | 1.17% | $119.40K |
| BioAge Labs Inc. | 1.15% | $117.06K |
| Maze Therapeutics Inc | 1.09% | $110.83K |
| Agpxx | 1.06% | $107.99K |
| Septerna Inc. | 0.96% | $98.07K |
| Wave Life Sciences Ltd. | 0.95% | $96.44K |
| Zevra Therapeutics Inc | 0.94% | $96.06K |
| Fulcrum Therapeutics Inc | 0.88% | $89.48K |
| Aquestive Therapeutics Inc | 0.78% | $79.04K |
| LB Pharmaceuticals Inc. | 0.69% | $69.79K |
| Alto Neuroscience Inc | 0.51% | $52.27K |
VPPM overview: performance, fees, allocation and SEC filings